Shares of Oncimmune Holdings plc (LON:ONC – Get Free Report) traded up 11.9% on Friday . The stock traded as high as GBX 15.55 ($0.20) and last traded at GBX 15.55 ($0.20). 950,601 shares traded hands during trading, an increase of 908% from the average session volume of 94,316 shares. The stock had previously closed at GBX 13.90 ($0.18).
Oncimmune Stock Performance
The company has a market cap of £11.57 million, a P/E ratio of -483.33 and a beta of 1.19. The company’s 50-day moving average price is GBX 17.06 and its two-hundred day moving average price is GBX 17.48. The company has a current ratio of 1.13, a quick ratio of 0.63 and a debt-to-equity ratio of 806.85.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Featured Stories
- Five stocks we like better than Oncimmune
- How to Invest in Blue Chip Stocks
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Why Are These Companies Considered Blue Chips?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Following Congress Stock Trades
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
